Skip to content

Huaiqi huang Granules combined with dexamethasone in the treatment of adult primary immune thrombocytopenia: a single center, randomized, controlled and open trial

Huaiqi huang Granules combined with dexamethasone in the treatment of adult primary immune thrombocytopenia: a single center, randomized, controlled and open trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004313
Enrollment
Unknown
Registered
2021-01-24
Start date
2021-01-24
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult newly diagnosed ITP

Interventions

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of adult primary ITP(PLT < 30 x 10^9/L). 2. Aged 18~70 years. 3. No serious heart, lung, liver, kidney and other functional diseases, no infection, diabetes, rheumatism, tumor, etc. 4. No history of special drugs such as glucocorticoid, immunosuppressant and traditional Chinese medicine within two weeksbefore entering the group. 5. Patients who are willing to receive treatment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Women during pregnancy and lactation. 2. Combined with serious heart, lung, liver, kidney diseases and malignant tumors, diabetes, mental illness,etc. 3. Not suitable to use . 4. Serious or uncontrolled infection. 5. Received special drugs such as glucocorticoid, immunosuppressant and traditional Chinese medicine within two weeks before entering the group. 6. Cannot follow up as scheduled. 7. The researcher believes that it is not suitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Blood routine;lymphocyte subsets;

Countries

China

Contacts

Public ContactLiangliang Ma

Department of Hematology, the First Affiliated Hospital of Dalian Medical University

maliangliangdy@163.com+86 18098875687

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026